GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (FRA:BXA0) » Definitions » Cash Flow for Lease Financing

Lavipharm (FRA:BXA0) Cash Flow for Lease Financing : €-1.21 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Lavipharm Cash Flow for Lease Financing?

Lavipharm's Cash Flow for Lease Financing for the six months ended in Jun. 2024 was €-0.39 Mil. Lavipharm's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jun. 2024 was €-1.21 Mil.

Compared with last quarter (€-0.82 Mil in Dec. 2023 ), Lavipharm's Cash Flow for Lease Financing increased in Jun. 2024 (€-0.39 Mil).

Lavipharm Cash Flow for Lease Financing Historical Data

The historical data trend for Lavipharm's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Cash Flow for Lease Financing Chart

Lavipharm Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial - - -0.68 -0.70 -1.19

Lavipharm Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.36 -0.34 -0.36 -0.82 -0.39

Lavipharm Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lavipharm Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Lavipharm's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Lavipharm Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (FRA:BXA0) » Definitions » Cash Flow for Lease Financing
Comparable Companies
BSE:PTR BSE:ARS BSE:TRANSI BSE:CMF BSE:ATB BSE:EVER BSE:COTE BSE:SCD BSE:VNC BSE:RMAH ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
LAVI:Greece
Address
Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002
Website
http://www.lavipharm.com
Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes innovative, safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines